Natco Pharma Limited — Updates, 18-09-2025: Press Release
18-09-2025 | 09:50 am
18-09-2025 | 09:50 am
NATCO Pharma's Kothur plant received a 'Voluntary Action Indicated (VAI)' classification from the U.S. FDA post-inspection. This positive outcome indicates minor observations, allowing voluntary corrections and lowering future regulatory risk for the facility.
No comments yet. Be the first to comment!
